Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 28, 2013; 19(8): 1210-1218
Published online Feb 28, 2013. doi: 10.3748/wjg.v19.i8.1210
Published online Feb 28, 2013. doi: 10.3748/wjg.v19.i8.1210
Figure 6 Effects of mitogen-activated protein kinases inhibitors on prostaglandin E2-induced action in interstitial cells of Cajal.
A: Pacemaker currents of interstitial cells of Cajal (ICCs) treated with 5 μmol/L prostaglandin E2 (PGE2) at a holding potential of -70 mV; B: Pacemaker currents after pretreatment with PD 98059 (10 μmol/L) prior to PGE2 treatment; C: Pacemaker currents after pretreatment with SB 203580 (10 μmol/L) prior to PGE2 treatment. The effects of mitogen-activated protein kinases inhibitors on the PGE2-induced action are summarized in D and E. Bars represent mean ± SE values (n = 4 per group). aP < 0.05 vs PGE2. Con: Control, PD: PD 98059, SB: SB203580.
-
Citation: Zuo DC, Choi S, Shahi PK, Kim MY, Park CG, Kim YD, Lee J, Chang IY, So I, Jun JY. Inhibition of pacemaker activity in interstitial cells of Cajal by LPS
via NF-κB and MAP kinase. World J Gastroenterol 2013; 19(8): 1210-1218 - URL: https://www.wjgnet.com/1007-9327/full/v19/i8/1210.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i8.1210